Keytruda beats chemo for first-line treatment against bowel cancer
Apr 03, 2020
Unfunded immunotherapy drug, Keytruda, has beaten standard chemotherapy in a head to head test to delay cancer progression showing its viability to be used as a first-line treatment for MSI-H bowel cancer patients around the world.
Read More (2 minute read)